News
12-09-2011, 03:11 AM
In a novel therapeutic approach to treating breast cancer, Loyola University Medical Center researchers are reporting positive results from a clinical trial of a drug that targets tumor stem cells. Existing cancer drugs are effective in killing mature cancer cells. But a handful of cancer stem cells are resistant to such drugs. They survive and go on to develop into new tumor cells...
More... (http://www.medicalnewstoday.com/releases/238875.php)
More... (http://www.medicalnewstoday.com/releases/238875.php)